Menlo Ventures' 2026 State of AI in Healthcare report highlights a significant shift in healthcare AI spending, reaching $3.7 billion—an increase of 2.5 times over the past year. This growth indicates a transition from administrative functions to more critical applications, such as drug discovery, clinical decision-making, and patient care. AI spending in life sciences grew 23-fold, suggesting pharmaceutical companies are increasingly relying on AI to expedite drug development processes. This report underscores the expanding role of AI in transforming healthcare, pointing towards a future where AI plays a pivotal role in improving health outcomes and reducing costs. Elsewhere in the market, HubSpot was trading firmly up 6.8% and closing at $231.98.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.
